2m children reached in Ghana, Kenya and Malawi with RTS,S makes me feel so proud. But further innovation is needed to stay ahead of malaria – it’s an evolving threat, so our scientists, along with our partners, must evolve with it #ChangeTheTrajectory youtube.com/watch?v=qN3nYm…

Get ready for #UnionConf2023 with episode 2 of our TB Voices series. This is Kevin’s powerful story. Through our partnership with Amref Health Africa, we've made a difference in Western Kenya, enhancing the prevention, diagnosis and treatment of TB. gsk.to/3QFZ6YX #EndTB

📣 Applications for this year’s #AfricaOpenLab are now open! This global health initiative supports early career African scientists’ research projects into infectious diseases that disproportionately affect sub-Saharan Africa. Learn more: gsk.com/AfricaOpenLab #CPHIA2023

By bringing to life Apsara’s story in #TheClimateAndUs series, we show why GSK is innovating and working in partnership to help #ChangeTheTrajectory of climate-aggravated diseases. Together, we can get ahead of the health impacts of climate change. youtube.com/watch?v=BRHkE0…

It was a pleasure to represent GSK’s Global Health team at #CPHIA2023 and have valuable discussions on the #globalhealth challenges faced in Africa. We’re continuing working closely with our partners to #ChangeTheTrajectory of infectious diseases in lower-income countries.

In partnership with @gsk and the Financial Times, Dr Githinji Gitahi, MBS, myself and Martin Edlund outline how we must #ChangeTheTrajectory by finding new ways to prevent and treat climate-aggravated diseases, together: gsk.ft.com/article/eradic…

We all have a role to play to #ChangeTheTrajectory of the impact of climate change on human health. At #COP28UAE, we hosted an insightful discussion with climate and health experts, reflecting on Health Day and the importance of turning conversation into action.

Cameroon has officially launched our malaria vaccine! I’m so proud of the GSK team and our partners for their work over 35+ years to develop the world’s first malaria vaccine. Great to finally see it rolled out in malaria endemic countries’ routine immunisation programmes.

It’s #WorldNTDDay! We’re committed to eliminating Neglected Tropical Diseases such as lymphatic filariasis (LF) everywhere and continuing our donations beyond the 11bn treatments already provided. Working with partners on early discoveries for 2 other NTDs is our 2nd commitment.

#ClimateChange and #NatureLoss are impacting human health, particularly in the Global South. I’ve teamed up with Will Evison from PwC UK to shed light on how the pharmaceutical industry can respond. Join the conversation and read article 👇linkedin.com/pulse/twin-cri…

We’ve dedicated over 20 yrs to developing an essential TB candidate vaccine, so we’re delighted that it’s moved into a Phase 3 trial with our partners, Bill & Melinda Gates Medical Research Institute. M72 is the 1st potential new #TB vaccine candidate in over 100 yrs that so far meets World Health Organization (WHO)’s target product profile.

Fantastic work being done by Carene and team as part of #ProjectAfricaGRADIENT. A truly valued collaboration with GSK , Novartis and SAMRC 👇

I’m joining the rest of the voices around the world on #WorldTBDay to say, “Yes! We Can End TB!” But no one can do it alone. It’s only through partnership that we’ll transform the way TB is prevented and treated 🤝 #EndTB

All patients deserve access to high quality healthcare, yet the needs of many go unmet due to preventable factors. This is why closing the health equity gap not only benefits those facing barriers to access, but society as a whole: gsk.to/43ZlvGP

Hear from Dr Tekete and Dr Ouédraogo about their #ProjectAfricaGRADIENT research projects, looking at how genetic diversity in populations in Mali and Burkina Faso could have an impact on malaria patients’ response to treatment #ZeroMalaria

Great to work with Malaria No More and others on this piece 👇 We’re united in the conviction that we will help change the trajectory of malaria in our lifetimes! newstatesman.com/spotlight/heal…

Next week, I’ll be at #WHA77. I'm really looking forward to speaking at the events below 👇 and most importantly, listening to what everyone has to say. Events like this offer a great opportunity to gather valuable insights. Hope to see you there!

The impact of climate change on health alongside AMR are two huge challenges hindering global health progress. Our chief global health officer Thomas Breuer, MD, MSc (Epidemiology) reflects what we can do in the face of these challenges in our latest Behind the gsk.to/3ViFgXi #WHA77

Fantastic insights from our panel on the #impactofRandD 👉 products need to get to market quickly 👉 we must consider the cost of not investing in global health R&D 👉 local manufacturing quickens impact 👉 collaboration is essential Read the report: bit.ly/3UT3G8d

Great to be at PolicyCuresResearch #WHA77 to discuss new report on ROI from global health R&D. The report offers a superb evidence base on the impact of global health investments and will be a valuable tool for advocacy towards donors and partners. (1/3)